In 2022, when Mpox was still monkeypox, I was looking at this as a screenplay…
Here’s how I might see this movie evolving…
There’s an explosion of immune dysregulation, autoimmunity and immune suppression following the the mass spike shot campaign that appears to get worse with each jab. Aggressive cancers, cardiac episodes, neurological diseases, POTS, and shingles are all on the rise. Flare-ups of old illnesses return and we see a resurgence of viral diseases that had previously been managed. Regulatory authorities panic and need a scapegoat for the increasingly obvious maladies that are becoming too widespread to suppress. One senior scientist (let’s call him Antonio Fraudchi) suggests we create a panic around a scary, poorly understood viral disease from Africa that has similar symptom profile to some of the things that are circulating. This way, the new explosion of illness can be attributed to the next public health crisis rather than being blamed on the failed policies and campaigns he devised and executed. It would also allow him to roll out the next wave of lucrative public health solutions that would line his pockets and keep the people under this spell, at least until the WHO sealed the deal and took things to the next level.
But I digress. This is real life. So I guess I’ll have to wait and see…
A day later I learned about the 2021 Monkeypox “Preparedness Exercise”… (because of course there was a monkeypox tabletop exercise).
Bioscience and biotechnology advances, while offering tremendous potential benefits, also present opportunities for accidental release or deliberate abuse of biological agents that could cause as much or more harm than COVID-19. Scientific and political leaders must take bold action to safeguard the global bioscience and biotechnology research and development enterprise to ensure that catastrophic accidents or deliberate misuse do not lead to the next global pandemic. To strengthen international capabilities to respond to the next pandemic, national and global leaders must build stronger public health and medical response capabilities that can scale to address very high-consequence biological events—potentially orders of magnitude more severe than what we have experienced during the past two years….
To address important gaps in key areas, NTI is working with international partners:
• To establish a new global biosecurity entity dedicated to reducing emerging biological risks that can accompany certain technology advances. Its mission will be to reduce the risks of catastrophic consequences due to accidents, inadvertent misuse, or deliberate abuse of bioscience and biotechnology by promoting stronger global biosecurity norms and developing tools and incentives to uphold them.
• To explore the possibility of establishing a new Joint Assessment Mechanism to investigate highconsequence biological events of unknown origin. This new mechanism would operate at the “seam” between existing mechanisms—including World Health Organization (WHO) outbreak investigation capabilities and the United Nations Secretary-General’s Mechanism for investigating alleged deliberate bioweapons use—thereby strengthening UN system capabilities to investigate pandemic origins.
• To advocate for establishing a catalytic, multilateral financing mechanism for global health security and pandemic preparedness. The goal is to accelerate sustainable biosecurity and pandemic preparedness capacity-building in countries where resources are most needed.
The exercise “simulated” a vaccine-resistant monkeypox outbreak that was a biological warfare attack. Who were the participants? Same old people from the Bill and Melinda Gates Foundation, China CDC, and so on.
Incidentally, many of the Mpox cases were among the vaccinated.
And speaking of biological warfare attack using monkeypox…
For nearly nine years Dr. Anthony Fauci’s institute concealed plans to engineer a pandemic capable mpox, formerly known as monkeypox, virus with a case fatality rate of up to 15%, congressional investigators revealed in a new report on June 11.
In June 2015, a scientist at the National Institute of Allergy and Infectious Diseases (NIAID) received formal approval from the National Institutes of Health’s (NIH) Institutional Review Board for experiments expected to engineer a mpox virus with high transmissibility and moderate mortality…
A new interim report describes the obstruction and secrecy around the mpox proposal as a case study of how the institute “oversees and accounts for the monitoring of potentially dangerous gain-of-function research of concern.”
The revelations land amid global concerns about whether coronavirus gain-of-function research — research that might generate pathogens with increased pathogenicity or transmissibility — may have contributed to the worst pandemic in a century.
The committee, in conjunction with the House Committee on Oversight and Reform, is also investigating coronavirus gain-of-function research underwritten by NIAID at the Wuhan Institute of Virology, and faces similar stonewalling in that investigation, a committee aide said.
The report details the Committee’s investigation, which was launched following a 2022 Science magazine interview in which Dr. Bernard Moss of the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) revealed that he was planning to insert segments of a lethal strain of MPXV (formerly known as “monkeypox”) into a more a transmissible strain of the virus. This proposed experiment alarmed some scientists concerned about the risks of creating an enhanced version of the MPXV virus.
For nearly a year and a half, the Department of Health and Human Services (HHS), the NIH, and NIAID misrepresented and deceived the Committee by repeatedly denying that the potentially dangerous experiment was proposed and approved. However, after being pressed repeatedly by Committee Leaders, HHS ultimately admitted Dr. Moss’s research team had been granted approval to conduct a bidirectional MPVX gene-transfer experiment (i.e., inserting the more lethal strain into the more transmissible strain and vice versa).
You can read the full report here.
And here’s NIH’s Dr. Bernard Moss seeding a Monkeypox narrative in the 2022 Science article:
Monkeypox is spreading mostly among men who have sex with men, and only about 60,000 cases have been reported so far, so it has much less opportunity to evolve.
That could change, however. One “bad scenario,” says Bernard Moss, a veteran poxvirus researcher at the U.S. National Institute of Allergy and Infectious Diseases, is that the virus evolves to replicate faster in humans. That would allow it to infect more people, which would in turn speed up its evolution, potentially making it still more adept at infecting people… (emphasis mine)
…Moss has been trying for years to figure out the crucial difference between two variants of monkeypox virus: clade 2, which until recently was found only in West Africa and is now causing the global outbreak, and clade 1, believed to be much deadlier, which has caused outbreaks in the Democratic Republic of Congo for many decades. He’s found that clade 1 virus can kill a mouse at levels 1000 times lower than those needed with clade 2. To find out why, Moss and his colleagues swapped dozens of clade 2 genes, one at a time, into clade 1 virus, hoping to see it become less deadly, but with no luck so far. Now, they are planning to try the opposite, endowing clade 2 virus with genes from its deadlier relative.
This is all easier to understand if you stop calling them tabletop exercises and start calling them plot lines or playbooks. We need to understand this if we’re going to write the ending.
70% of Monkeypox in COV-2 Vaxxed - Major Studies Scrubbed and Found!
https://talknet.substack.com/p/70-of-monkeypox-in-cov-2-vaxxed-major
this is all just background paperwork to cover for 5G emf activated illness. If you are harboring enough material, the frequencies broadcast will manifest as this pox. They are telling us they are about to flip the switch.